<DOC>
	<DOCNO>NCT01567332</DOCNO>
	<brief_summary>Recovery neurological deficit stroke result reorganization cortical activity , possibly brain plasticity . Repetitive Transcranial Magnetic Stimulation ( rTMS-MagproR30 ) produce change cortical excitability , generate phenomena neuroplasticity . Its use improve function stroke , particularly upper limb , validate . The investigator propose evaluate prospective pilot placebo , benefit rTMS low frequency ( 1Hz ) unaffected hemisphere short medium term , especially walk function spasticity patient sequelae cerebral infarction MCA territory gait disturbance motor weakness upper limb .</brief_summary>
	<brief_title>Evaluation Walking After Repetitive Transcranial Magnetic Stimulation ( rTMS ) Inhibitory 1Hz Vascular Hemiplegia</brief_title>
	<detailed_description />
	<mesh_term>Hemiplegia</mesh_term>
	<criteria>Age 1880 year two sex Cerebral infarction old 12 month NIH score &gt; 4 Patient able walk without technical assistance , Rankin score great equal 3 No change interfere treatment spasticity 3 month precede study ( benzodiazepine , baclofen , dantrolene , botulinum toxin ... ) No history generalize epilepsy unbalanced Free inform consent sign patient MRI ancient anatomical sequence confirm accident sylvian Stroke motor sequelae cerebral infarction prior qualify Alteration course prior stroke Generalized epilepsy unbalance Arrhythmias untreated Injection botulinum toxin previous 4 month randomization 2 month randomization Severe aphasia cognitive impairment interferes understand task Presence ferromagnetic material intracranial Pacemaker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>